Records containing: Metastatic Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-09-16A Phase II Study to Evaluate the Safety and Efficacy of Rigosertib (ON 01910) Plus Pembrolizumab in Patients With Metastatic Melanoma Refractory to Immune Checkpoint Blockade
-
CLINICAL_TRIALS study results posted · 2026-09-10Phase Ib/II Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study results posted · 2026-06-04A Multicenter Phase 2 Trial to Evaluate Intracranial Response to Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma Who Are Anti-PD1/PD-L1 Experienced
-
CLINICAL_TRIALS study record update · 2026-04-27A Phase II Study to Evaluate the Safety and Efficacy of Rigosertib (ON 01910) Plus Pembrolizumab in Patients With Metastatic Melanoma Refractory to Immune Checkpoint Blockade
-
CLINICAL_TRIALS study record update · 2026-04-23Safety and Efficacy of SRS and Immune Checkpoint Inhibitors (ICI) Concurrent With NovoTTF-200M in Melanoma Brain Metastases
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-21Phase I/II Study of Aerosol Interleukin-2 for Pulmonary Metastases
-
CLINICAL_TRIALS study record update · 2026-04-21A Multi-center Trial Evaluating the ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab for Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-20Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release
-
CLINICAL_TRIALS study record update · 2026-04-20A Feasibility Phase I Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase 2, Multicenter, Open-label Study of Lifileucel (Tumor-infiltrating Lymphocytes [TIL]) in Participants With Previously Treated Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase II Clinical Trial Evaluating the Efficacy of Combining Thermal Ablation and Spine Stereotactic Radiosurgery for Patients With Spine Metastases With Moderate to Severe Epidural Involvement
-
CLINICAL_TRIALS study record update · 2026-04-16Phase II Study of Binimetinib With Encorafenib in Patients With Metastatic Melanoma and CNS Metastases
-
CLINICAL_TRIALS study record update · 2026-04-16Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-15Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases
-
CLINICAL_TRIALS study record update · 2026-04-15A Pilot Study of Lymphodepletion Plus Adoptive Cell Transfer With TGF-Beta Resistant (DNRII) and NGFR Transduced T-Cells Followed by High Dose Interleukin-2 in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-15Phase II Study of BEvacizumab (Avastin) in Combination With Atezolizumab or Atezolizumab (Tencentriq) and Cobimetinib (Cotellic) in Patients With Untreated Melanoma Brain Metastases (TACo-BEAT-MBM)
-
CLINICAL_TRIALS study record update · 2026-04-15Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 2 Study of Nivolumab and Ipilimumab in Combination With Sirolimus and Prednisone in Kidney Transplant Recipients With Selected Unresectable or Metastatic Cutaneous Cancers
-
CLINICAL_TRIALS study record update · 2026-04-13Randomized Double-Blind Placebo Controlled Phase II Study of a Galectin-3 Inhibitor (GB1211) and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2026-04-13Phase I/II Study of Dabrafenib, Trametinib, and Navitoclax in BRAF Mutant Melanoma (Phase I and II) and Other Solid Tumors (Phase I Only)
-
CLINICAL_TRIALS study record update · 2026-04-13Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) - A Phase II Study of Combining Cabozantinib and Nivolumab in Participants With Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers - an immunoMATCH Pilot Study
-
CLINICAL_TRIALS study record update · 2026-04-13Phase I Study of the Combination of the VEGFR Inhibitor, AZD2171, and MEK Inhibitor, AZD6244, in the Treatment of Solid Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1 Trial of MK-3475 Plus Ziv-Aflibercept in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-06A Randomized, Pilot Study to Evaluate the Molecular and Cellular Response to Treatment With Nivolumab With Either Adjuvant Ipilimumab or Relatlimab in Adult Patients With Surgically Resectable Melanoma Brain Metastases
-
CLINICAL_TRIALS study record update · 2026-04-06Phase II Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma